Stock listing
ATRC Stock Price, News, Filings & Events — Atricure, Inc.
Selected listing: ATRC · NASDAQ · USD · US
This page tracks Atricure, Inc.'s ATRC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATRC:NASDAQ. ATRC:NASDAQ is the stock-level entry point for investors researching Atricure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.77 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.

- Ticker
- ATRC:NASDAQ
- Asset type
- Stock
- Market cap
- $2.49B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Atricure, Inc. ATRC:NASDAQ stock context
This page tracks Atricure, Inc.'s ATRC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ATRC:NASDAQ. ATRC:NASDAQ is the stock-level entry point for investors researching Atricure, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.77 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.
Latest news from Atricure, Inc.
AtriCure to Participate in the 2026 Wells Fargo Health Care Conference
August 25, 2026
AtriCure Reports Second Quarter 2026 Financial Results
July 23, 2026
AtriCure to Announce Second Quarter 2026 Financial Results
July 2, 2026
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference
May 27, 2026
AtriCure Reports First Quarter 2026 Financial Results
May 5, 2026
Research Atricure, Inc.
Atricure, Inc. investor report
Review AI stock analysis and investor report context for ATRC:NASDAQ.
Atricure, Inc. company profile
View the public company page for Atricure, Inc. on 6ix.
Atricure, Inc. news
Read company news and market updates connected to Atricure, Inc..
Atricure, Inc. investor events
Find investor webinars, events, and replay context for Atricure, Inc..
Alternate listings
A5I:FWB
DE · EUR
Alternate listing for Atricure, Inc.; the primary context on this page is ATRC:NASDAQ.
A5I:TRADEGATE
DE · EUR
Alternate listing for Atricure, Inc.; the primary context on this page is ATRC:NASDAQ.
ATRC:BOATS
US · USD
Alternate listing for Atricure, Inc.; the primary context on this page is ATRC:NASDAQ.
A5I:DUS
DE · EUR
Alternate listing for Atricure, Inc.; the primary context on this page is ATRC:NASDAQ.
A5I:HAM
DE · EUR
Alternate listing for Atricure, Inc.; the primary context on this page is ATRC:NASDAQ.